Patent Expiry
HALO: TLANDO: recorded patent 11364249 expiry
November 30, 2030 · TESTOSTERONE UNDECANOATE. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- November 30, 2030
- Company
- HALOZYME THERAPEUTICS, INC. (HALO)
- Drug
- TESTOSTERONE UNDECANOATE
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
TLANDO: recorded patent 11364249 expiry
Orange Book application NDA208088, product 001, listed patent 11364249 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source